★

BIODYNE

Large Shareholding Report Filed (No Specific Changes Disclosed)

  • The report was filed in the form of a large shareholding status report, but specific figures such as changes in the number and ratio of shares held were not disclosed.
  • Call option exercise period: 2026.02.06 ~ 2026.08.05
  • Shares subject to pledge may be recalculated and changed based on stock price fluctuations.
  • No shareholder return-related content.

KOSDAQ Filing Information

  • Filing: Report on Large Shareholding (General)
  • Company: BIODYNE (314930)
  • Submission: Ukbin Im
  • Receipt: 05-15-2026

Learn more

More disclosures
Company Information
DART
Naver Finance
Daum Finance
Google Finance
Yahoo Finance